Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9IXT

Crystal structure of TEAD3 YAP binding domain with compound 2

これはPDB形式変換不可エントリーです。
9IXT の概要
エントリーDOI10.2210/pdb9ixt/pdb
分子名称Transcriptional enhancer factor TEF-5, ~{N}-[(1~{S})-4-azanyl-4-oxidanylidene-1-phenyl-butyl]-5-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1~{H}-isoquinoline-2-carboxamide (3 entities in total)
機能のキーワードtranscription factor, tead3, transcription
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数3
化学式量合計77803.28
構造登録者
Yoo, Y. (登録日: 2024-07-29, 公開日: 2025-04-16)
主引用文献Kim, J.K.,Kim, J.,Kim, H.,Jin, H.,Yoo, Y.,Fei, X.,Maeng, H.J.,Seo, S.Y.,Han, G.,No, K.T.
Structure-based optimization of TEAD inhibitors: Exploring a novel subpocket near Glu347 for the treatment of NF2-mutant cancer.
Bioorg.Chem., 159:108425-108425, 2025
Cited by
PubMed Abstract: The Hippo signaling pathway is critical for regulating cell growth, tissue homeostasis, and organ size. Dysregulation of this pathway has been associated with a range of pathologies, especially cancer, through its modulation of downstream effectors-Yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ). These proteins bind to transcriptional enhanced associate domain (TEAD) proteins and function as transcription factors in the nucleus, producing oncogenic target genes such as CTGF and CYR61. TEAD proteins require palmitoylation via a covalent bond with cysteine in the central pocket to bind YAP/TAZ. Therefore, competitive inhibition that prevents palmitoylation could serve as an effective anticancer strategy. In this study, we analyzed the crystal structures of the known inhibitor VT-105 bound to TEAD3 to identify new binding spots that were previously unexplored, with the aim of discovering more potent compounds using structure-based drug design. Consequently, we identified a novel hydrogen-bonding site and discovered C-2, which effectively binds to this site, as confirmed by X-ray crystallography. Furthermore, C-2 exhibited stable pharmacokinetic properties and demonstrated impressive efficacy in a mouse xenograft model.
PubMed: 40168885
DOI: 10.1016/j.bioorg.2025.108425
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.5 Å)
構造検証レポート
Validation report summary of 9ixt
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon